Skip to main content

Funding Update: Apr 15, 2011

Premium

Recent NSF Awards in Proteomics and Protein Research

Title: Waterborne Chemical Cues in the Plankton: A Systems Biology Approach
Principal Investigator: Julia Kubanek, Facundo Fernandez
Sponsor: Georgia Institute of Technology
Start/End Date: Oct. 1, 2011 – Sep. 30, 2014
Amount Awarded to Date: $545,870

Funds a project to investigate the release of chemicals by phytoplankton as a means of inhibiting environmental competitors. The project will use mass spec-based proteomics to investigate the protein expression of the red tide dinoflagellate Karenia brevis to see what proteins are up- or down-regulated in response to challenges by competitors.


Title: Photonic Devices Based on Fluorescent Proteins
Principal Investigator: Seok Yun
Sponsor: Massachusetts General Hospital
Start/End Date: July 1, 2011 – June 30, 2014
Amount Awarded to Date: $360,000

Funds an effort to investigate the optical amplification characteristics of fluorescent proteins with the ultimate aim of developing protein-based lasers that could be used in imaging and analyte sensing for bioengineering and medical diagnosis.


Title: Impedance-Based Bioelectronic Tongue that Incorporates Antibodies
Principal Investigator: Ian Suni, Stephanie Schuckers
Sponsor: Clarkson University
Start/End Date: June 1, 2011 – May 31, 2014
Amount Awarded to Date: $345,485

Funds work on developing a bioelectronic tongue for the detecting of proteins using an array of antibody-coated electrodes interrogated by impedance methods. The researchers will demonstrate the simultaneous detection of three allergenic proteins from a protein mixture using the device.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.